Abdominal Bloating. Flatulence
Conditions
Interventions
Intervention 1: Intervention group 1: At first, for 2 weeks, they will receive 500 mg Metronidazole Tablet of Pars Daru three times a day, and after 2 weeks, they will receive 500 mg FamiLact Probioti
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: Age between 20 and 50 years Having functional abdominal distention according to the Rome III criteria The first experience of bloating is more than 6 months before the study Abdominal bloating feeling at least 3 days a month in the last 3 months Consent to participate in the study
Exclusion criteria
Exclusion criteria: Any history of chronic inflammatory disease or structural disease of the gastrointestinal tract Any serious physical problem or disease such as inflammation or malignancy ?Abnormal laboratory data Use of Calcium Channel Blocker drugs in the last 3 months Severe stress in the last 6 months Positive family history for colon cancer Pregnancy or breastfeeding\
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Abdominal Bloadting. Timepoint: Before the start of the study, 2 weeks after the start of the study, 4 weeks after the start of the study, 6 weeks after the start of the study and 8 weeks after the start of the study. Method of measurement: Questionnaire for bloating and IBS-QOL questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Maryam Soheilipour
Esfahan University of Medical Sciences
Outcome results
None listed